| Nuvilex, Inc. (OTCBB: NVLX)
Nuvilex, Inc. is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. Accessibility, affordability, safety, efficacy, quality and value are paramount in the manufacturing, marketing and distribution of their products.
PRODUCTS
INFINITINK
Infinitink is a high quality tattoo ink that is engineered to be permanent and safe — yet it is far easier to remove than traditional tattoo inks. Infinitink is applied to the skin in the same way as any other tattoo. It also stays in the skin for as long as you wish. If, however, you choose to have your Infinitink tattoo removed, it will come out of the skin in fewer treatments than tattoos made with traditional inks. Their studies have shown that Infinitink tattoos are up to three times more easy to remove than conventional tattoos. Three times less costly. Three times less painful. And three times less hassle.
An Infinitink tattoo is permanent yet removable because of its construction. The ink is made of the highest purity D&C and USP-grade ingredients. In addition, we use a patented proprietary process (P2E) to treat the pigments suspended in the ink. Our scientists have perfected the dissolution of the pigment so that, when passed over with a laser, the tattoo will be removed with fewer laser treatments than a conventional tattoo.
TALSYN
Talsyn, a cream for scars, is a synergistic blend of fatty acids, peptides, and complimentary botanical extracts. Talsyn has a pleasant aroma and—unlike many other skin creams—will not damage or stain fabrics.
Talsyn helps to improve the appearance of damaged skin and has been clinically proven to help facilitate skin healing. Many leading plastic and reconstructive surgeons use Talsyn and recommend it to their patients.
Talsyn is for the serious management of Keloids, Hypertrophic Scars, Erythema, and Surgical Incisions. Talsyn has been clinically proven to facilitate healing and improve the appearance, redness, and tensile strength of scars. Talsyn is used and endorsed by leading plastic and reconstructive surgeons.
This proprietary patent pending blend of ingredients has the unique ability of penetrating deep into the layers of the skin where wound healing occurs. Synthesis of new collagen which is vital to the process of wound healing is stimulated. Other ingredients deliver anti-inflammatory and wound healing properties. Numerous nutrients in Talsyn’s botanicals help create an optimal environment for the skin to repair itself in the fastest, most efficient organized configuration; thus allowing the scar to most closely resemble its original skin integrity.
Skin is the body’s protective barrier. When skin is damaged due to trauma, surgery or infection, a scar forms as the skin heals. A scar is made up of fibrous connective tissue. The size, depth, and severity of a scar are determined by several factors such as location, direction of the wound, a person’s age, and nutritional status. Improvement of the scar and proper healing of the incision or damaged skin is also dependent upon age, nutritional health, and specific characteristics of the scar. Improvement of incisions and damaged skin can also be enhanced and expedited by the application of Talsyn-CI once the wound is closed. Talsyn-CI has been clinically shown to improve the appearance and condition of existing scars. Results can be seen in as little as two to four weeks.
CINNERGEN
Given how out-of-balance the typical American diet has become, it's no wonder that millions of us either already suffer from or are at risk of developing blood sugar imbalances. We eat way too many simple sugars, way too often. Candy, french fries, potato chips, ice cream, pasta and more they all cause a rapid rise in blood sugar, followed by a rise in insulin which in turn causes blood sugar to plummet.
Eventually, this drastic up-and-down activity begins to take its toll on the body’s ability to metabolize sugar, leading to the onset of blood sugar problems. Emerging science suggests that Cinnergen helps promote normal blood sugar levels thereby decreasing symptoms that accompany elevated blood sugar and its effects.
Peer-reviewed research suggests that health-promoting chemicals contained in Cinnergen help to:
· Promote normal blood sugar levels
· Reduce blood glucose levels
· Minimize insulin resistance
· Promote healthy glucose metabolism
· Fight obesity and promote healthy weight loss
One dose (1 fl. Oz.) of Cinnergen delivers amino acids (the building blocks of protein), vitamins, minerals, enzymes, antioxidants, and over a dozen all-natural chemicals derived from plants (including cinnamon bark extract, blueberry leaf extract, ginger root extract, and kelp extract) to the body.
LAST SHOT
Last Shot is a ground-breaking nutritional supplement formulated to help ease the effects of alcohol consumption before they occur. Last Shot is a liquid, easily taken or mixed into a drink – no popping pills or mixing powders. Last shot is calorie free, sugar free, and caffeine free.
Each 20mL Last Shot delivers a proprietary formula paced with vitamins, amino acids, phytochemicals, and bioflavinoids. Antioxidant activity triggered by these ingredients helps transport toxins out of the body while supplementing vital nutrients.
Key ingredients and how they work:
Cinnamon Bark Extract – regulates blood sugar
White Willow Bark Extract – a natural analgesic
Vitamins B1, B12 – reduces fatigue
Selenium – Strengthens the immune system
Kelp Extract – Helps filter out toxins
Ginseng – Promotes clear thinking
L-carnitine – minimizes muscle fatigue
LEADERSHIP
Martin Schmieg, Chairman and Chief Executive Officer
Martin Schmieg has over 20 years of experience launching and building businesses in the medical device, biotechnology and life sciences industries. Prior to Nuvilex, Martin repeatedly transitioned companies with innovative technologies to successful product based enterprises, while increasing valuation through his proven financial management, negotiation skills and aggressive fundraising capabilities. Working with companies such as Sirna Therapeutics, Advanced Bionics and Cytometrics, he raised capital in excess of $55 million for one enterprise, raised the market capitalization of another from $0 to $200 million, and was the financial architect of a $4.2 billion sale of a third company to a Fortune 500 company. Martin's executive experience spans operating functions including finance and management to marketing and business strategy. He holds a BS in Business Administration from LaSalle University and is a Guest Lecturer at the MIT Sloan School of Management and at the University of Pennsylvania's School of Engineering, Arts and Sciences. He is a Mentor at the Port of Technology, University City Science Center's business development incubator. He is a CPA in Pennsylvania.
Blair Barnes, Chief Financial Officer
Blair Barnes brings over 25 years of experience in finance, business analysis and capital fund raising to Nuvilex. With an extensive background in investment banking and hedge fund management, she has repeatedly improved the performance and added investors to funds for firms such as Craig Drill Capital, Bedford Oak Advisors and Henderson Brothers, Inc. Most recently as the VP of Business Development for Nuvilex, Blair was instrumental in raising three rounds of financing to launch the company. She is the treasurer and secretary for the company. Blair began her career in finance as an assistant trader at Lehman Brothers. She holds a BA from Sweet Briar College in Political Economics and Business.
Christine Solari, Senior Vice President of Research, Development, and Manufacturing
Christine's experience with processes, people and chemistry was gained during her tenure at the DuPont Experimental Station (Wilmington, DE). At DuPont she led cross functional teams in the development and successful delivery of ink-jet printer inks to several worldwide OEM customers. In addition, she developed a specific set of processes that increased ink manufacturing capacity by 25% without capital investment or quality issues. Prior to her work on the ink manufacturing process, Christine developed the 2nd generation black ink dispersion which gained $8MM/yr PTOI for DuPont.
Christine holds a Bachelor of Science (Cum Laude) and a Master of Science in Chemical Engineering from Drexel University.
|
